AbbVie officially began construction on its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, ...

AbbVie (ABBV) announced the start of construction of its new active pharmaceutical ingredient manufacturing plant in North ...

Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. This ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling ...

Manufacturers in Europe and the United States have announced plans for new in-country API development and manufacturing capabilities. Manufacturers in Europe and the United States have announced plans ...

Lilly plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in ...

Government regulations that favor API development and changes in geopolitical conditions are driving market expansion. The expansion is due to advancements in manufacturing active pharmaceutical ...

AbbVie started construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois.